Health software company Volpara Health Technologies (ASX:VHT) reports their trial in breast cancer screening had excellent results in the second-round.
The study used Volpara®Density™ software to assess breast density. The results showed a significant reduction in interval cancers in those women being selected for breast MRI. False-positive rate significantly reduced relative to first results two years ago.
Shares in Volpara Health Technologies (ASX:VHT) are trading 2.3 per cent higher at $1.32.
21 Nov 2019 - Redflex Holdings (ASX:RDF) US subsidiary, Redflex Traffic Systems, has today entered into a major agreement with the Los Angeles County Metropolitan Transportation Authority to provide photo enforcement and violation processing services.
20 Feb 2020 - EBOS (ASX:EBO) today announced strong growth in revenue and earnings for the first half of FY 2020 showing statutory NPAT at $81.7 million up 21.8 per cent on the prior corresponding period.
20 Jan 2020 - Diversified online retailer, Kogan.com (ASX:KGN) has recorded the highest half yearly gross sales and gross profit in the company’s history.
10 May 2021 - A snapshot of stocks making headlines for the hour featuring Crown Resorts (ASX:CWN), Woolworths (ASX:WOW) & PointsBet Holdings (ASX:PBH).
18 Feb 2020 - Hearing implant manufacturer Cochlear's (ASX:COH) reported net profit increased by 23 per cent to $157.7 million and includes $25.0 million in non-cash after-tax gains from the revaluation of innovation fund investments.
03 Aug 2020 - Zenviron, a Monadelphous (ASX:MND) joint venture, has won an $80 million contract with General Electric to build a wind farm in Victoria.
07 Apr 2021 - Australian waste management company Cleanaway (ASX:CWY) has been accused, by its French competitor Veolia (EPA:VIE), of having unfair advantages in purchasing Suez’s recycling and recovery assets in Australia.
29 Jan 2020 - Treasury Wine Estates (ASX:TWE) have reduced their guidance for the 2019-20 financial year mainly due to underperformance in the US markets.
31 Mar 2023 - Hear the latest from DNR Capital Chief Investment Officer and PM of the Australian Equities High Conviction Strategy Jamie Nicol as he provides his thoughts on the recent reporting season and where he sees market opportunities in its wake.
